Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

BISMUTH SUBSALICYLATE TABLETS

Awarded
SPE2DP26F6871Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Delivery order SPE2DP26F6871, issued on June 30, 2026, by the Defense Logistics Agency Troop Support Medical Supply Chain Pharm FSA, awards DMS Pharmaceutical Group Inc. the supply of Bismuth Subsalicylate Tablets. This order is placed under the basic contract SPE2DX25D9900 for a total value of $12.80, covering 8 packages at a unit price of $1.60. The awardee is identified as a small business, a small disadvantaged business, and a women-owned small business. The contractor is responsible for delivering the items to Smith Barracks in Baumholder, Germany, by July 15, 2026. The terms are FOB Destination, meaning the contractor bears all transportation costs and risks until the goods reach the destination, where the government will perform final inspection and acceptance. Packaging and marking must comply with DLA procedural notes C19 and C20, and all shipments must be clearly marked with the contract and delivery order numbers. Payment is processed through the Defense Finance and Accounting Service in Columbus, Ohio.

General Info

DMS Pharmaceutical Group supplies Bismuth Subsalicylate Tablets to Germany for $12.80 by July 2026.

Contract Value

$12.8

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2DP-26-F-6871 - Order for Bismuth Subsalicylate Tablets

PDF, High priority: read this firsttask-order-award
High

SPE2DP26F6871.pdf

PDF, Low priorityother
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F6871 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $12.80 Award Date: 06-30-2026 Delivery order under: SPE2DX25D9900 Line items: - BISMUTH SUBSALICYLATE TABLETS (NSN/Part 6505014437607, PR 7017361828)

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
Atropine Auto-Injector
Solicitation # SPE2DP-27-R-ATRO
DLA Troop Support is conducting market research via a sources sought notice for the procurement of Atropine Auto-Injectors under solicitation SPE2DP-27-ATRO. The agency intends to award a firm-fixed price, indefinite delivery, indefinite quantity contract consisting of a one-year base term and four one-year option terms. The required devices must deliver 1.67 mg of atropine base (equivalent to 2 mg atropine sulfate) and be 99.5 percent reliable, with a dispensing time of 0.5 seconds and an activation force between 0.90 and 3.60 kg. All products must be FDA approved per NDA No. 212319, comply with USP sterility standards, and maintain a minimum shelf life of 24 months upon delivery to DLA Distribution Susquehanna in New Cumberland, Pennsylvania. Strict packaging and marking requirements are mandated, including individual sealed polyethylene bags, intermediate boxes of 40 units, and exterior containers of 480 units, all conforming to MIL-STD-2073-1 and ASTM D4169-16. Labels must include specific dosage, storage, and usage instructions for nerve agent and insecticide poisoning. Interested respondents must provide their CAGE code, business size under NAICS 325412, and certification of commerciality per FAR 2.101. Manufacturers must submit FDA registration, while authorized distributors must provide a letter of commitment from the manufacturer. Responses are due by December 1, 2026.
DLA Troop Support

POSTED

about 6 hours ago

DEADLINE

in about 1 month
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS